Ampio Pharmaceuticals, Inc. (AMPE)
OTCMKTS: AMPE · Delayed Price · USD
0.0022
0.00 (0.00%)
Aug 29, 2024, 4:00 PM EDT - Market closed
Ampio Pharmaceuticals Employees
Ampio Pharmaceuticals had 6 employees as of December 31, 2023. The number of employees decreased by 2 or -25.00% compared to the previous year.
Employees
6
Change (1Y)
-2
Growth (1Y)
-25.00%
Revenue / Employee
n/a
Profits / Employee
-$1,438,667
Market Cap
2.50K
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 440,000 |
Johnson & Johnson | 131,900 |
Thermo Fisher | 122,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 89,900 |
Novartis AG | 76,057 |
Merck & Co. | 72,000 |
Novo Nordisk | 64,319 |
AMPE News
- 5 months ago - Ampio Pharmaceuticals Received Audit Opinion with Going Concern Explanation - PRNewsWire
- 5 months ago - Ampio Announces Voluntary Delisting and SEC Deregistration - PRNewsWire
- 7 months ago - Ampio Provides Update on Results from Pre-IND Enabling Studies - PRNewsWire
- 8 months ago - Ampio Provides Litigation Update - Reports Settlement in Principle of Certain Pending Legal Actions - PRNewsWire
- 10 months ago - Ampio Pharmaceuticals to Present at the Emerging Growth Conference - PRNewsWire
- 11 months ago - Ampio Selects Ascendia Pharmaceuticals, Inc. to Provide CDMO Services to Support Clinical Development of OA-201 - PRNewsWire
- 1 year ago - Ampio Pharmaceuticals Announces Reverse Stock Split - PRNewsWire
- 1 year ago - Ampio Pharmaceuticals Announces Series D Preferred Stock Dividend to its Holders of Common Stock - PRNewsWire